Compare RSI & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RSI | AXGN |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2020 | 2013 |
| Metric | RSI | AXGN |
|---|---|---|
| Price | $22.55 | $34.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $23.40 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 1.4M | 798.9K |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 933.33 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $1,134,428,000.00 | $225,208,000.00 |
| Revenue This Year | $25.26 | $20.60 |
| Revenue Next Year | $14.22 | $16.45 |
| P/E Ratio | $73.69 | ★ N/A |
| Revenue Growth | ★ 22.76 | 20.21 |
| 52 Week Low | $11.12 | $9.22 |
| 52 Week High | $23.15 | $36.00 |
| Indicator | RSI | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 61.28 | 56.00 |
| Support Level | $20.56 | $29.48 |
| Resistance Level | $22.74 | $34.60 |
| Average True Range (ATR) | 0.85 | 1.72 |
| MACD | -0.00 | 0.23 |
| Stochastic Oscillator | 81.75 | 81.83 |
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.